首页>
外国专利>
Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug
Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug
展开▼
机译:评估仿制药与相应原始药物生物等效性的生物等效性评价方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
[Problem] There is provided a bioequivalence evaluation method not only of evaluating bioequivalence between an original drug and a corresponding generic drug but also of enabling to compare bioequivalence between generic drugs.;[Means of Solving the Problem] The bioequivalence between generic drugs is evaluated according to the Expression (1) wherein CCVCmax g stands for the calibration coefficient of variation of Cmax (the maximum blood concentration), CCVTmax g stands for the calibration coefficient of variation of Tmax (the time to maximum blood concentration), CCVT1/2 g stands for the calibration coefficient of variation of the half-life (T1/2), and CCVAUC g stands for the calibration coefficient of variation of AUC (the blood concentration-area under the curve).
展开▼
机译:[问题]提供了一种生物等效性评估方法,该方法不仅可以评估原始药物与相应的仿制药之间的生物等效性,而且还可以比较仿制药之间的生物等效性。[解决问题的方法]评估了仿制药之间的生物等效性根据表达式(1),其中CCV Cmax g Sub>代表Cmax(最大血药浓度)变化的校准系数,CCV Tmax g Sub>代表Cmax的校准系数。 Tmax(达到最大血药浓度的时间)的变化CCV T1 / 2 g Sub>代表半衰期变化的校准系数(T 1/2 Sub>), CCV AUC g Sub>代表AUC(曲线下的血药浓度-面积)变化的校准系数。
展开▼